Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/NOT stock hub

FRA/NOT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/NOTis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
236.4B
Frankfurt Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
FRA/NOT
In the news

Latest news · FRA/NOT

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.2
P25 n/aP50 n/aP75 n/a
Trailing P/E20.1
P25 n/aP50 n/aP75 n/a
ROE34.9
P25 n/aP50 n/aP75 n/a
ROIC21.1
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/NOT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
218
Groups with data
11
Currency
USD
Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
Switzerland
Country code
DE
Employees
75,267
Employees Change
-616%
Employees Change Percent
-0.81
Enterprise value
EUR 271.9B
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Last refreshed
2026-05-10
Market cap
EUR 236.4B
Price
EUR 124
Price currency
EUR
Rev Per Employee
651,947.06x
Sic
2834
Symbol
fra/NOT
Website
https://www.novartis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
4.97%
EV Earnings
23.16x
EV/EBIT
16.85x
EV/EBITDA
13.37x
EV/FCF
17.88x
EV/Sales
5.48x
FCF yield
6.43%
Forward P/E
16.23x
P/B ratio
7x
P/E ratio
20.14x
P/S ratio
4.82x
PE Ratio10 Y
20.03x
PE Ratio3 Y
18.04x
PE Ratio5 Y
17.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
32.56%
EBITDA Margin
40.51%
FCF margin
30.99%
Gross margin
75.55%
Gross Profit
EUR 37.1B
Gross Profit Growth
6.14%
Gross Profit Growth Q
-2.95%
Gross Profit Growth3 Y
10.99%
Gross Profit Growth5 Y
3.98%
Net Income
EUR 11.7B
Net Income Growth
5.25%
Net Income Growth Q
-12.48%
Net Income Growth3 Y
24.42%
Net Income Growth5 Y
11.21%
Pretax Margin
27.9%
Profit Margin
23.92%
Profit Per Employee
EUR 155,952
ROA
10.54
Roa5y
7.4
ROCE
21.14
ROE
34.93
Roe5y
23.91
ROIC
21.1
Roic5y
17.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

21
MetricValue
Cagr1y
30.54%
Div CAGR10
4.72%
Div CAGR3
7.48%
Div CAGR5
5.86%
EPS Growth
9.48
EPS Growth Q
-9.34
EPS Growth3 Y
29.06
EPS Growth5 Y
14.94
FCF Growth
-0.4%
FCF Growth Q
-1.8%
FCF Growth3 Y
6.01%
FCF Growth5 Y
7.94%
OCF Growth
0.93%
OCF Growth Q
0.85%
OCF Growth10 Y
5.03%
OCF Growth3 Y
7.25%
OCF Growth5 Y
7.67%
Revenue Growth
6.31x
Revenue Growth Q
-0.71x
Revenue Growth3 Y
10.71x
Revenue Growth5 Y
2.55x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
EUR 0.52
Assets
EUR 102.8B
Cash
EUR 6B
Current Assets
EUR 22.6B
Current Liabilities
EUR 26.6B
Debt
EUR 40.8B
Debt EBITDA
EUR 2.03
Debt Equity
EUR 1.21
Debt FCF
EUR 2.68
Equity
EUR 33.8B
Interest Coverage
15.14
Liabilities
EUR 69B
Long Term Assets
EUR 80.2B
Long Term Liabilities
EUR 42.4B
Net Cash
EUR -34.8B
Net Cash By Market Cap
EUR -14.72
Net Debt EBITDA
EUR 1.75
Net Debt Equity
EUR 1.03
Net Debt FCF
EUR 2.29
Tangible Book Value
EUR -24.7B
Tangible Book Value Per Share
EUR -12.96

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.85
Inventory Turnover
2.28
Net Working Capital
EUR -3.3B
Quick ratio
0.53
Working Capital
EUR -4.1B
Working Capital Turnover
EUR -8.7

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
3.8%
Dividend Growth
17.07%
Dividend Growth Years
4%
Dividend per share
EUR 4.1
Dividend Years
27
Dividend Yield
3.33%
Ex Div Date
2026-03-10
Last Dividend
EUR 4.1
Payout Frequency
Annual
Payout Ratio
64.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

32
MetricValue
1Y total return
30.51%
200-day SMA
118.2
50-day SMA
130.9
50-day SMA vs 200-day SMA
50over200
All Time High
144.1
All Time High Change
-13.85%
All Time High Date
2026-03-02
All Time Low
94.56
All Time Low Change
31.26%
All Time Low Date
2025-05-15
ATR
2.55
Ch YTD
5.1
High
124.1
High52
144.1
High52 Date
2026-03-02
High52ch
-13.85%
Low
122.9
Low52
94.56
Low52 Date
2025-05-15
Low52ch
31.26%
Ma50ch
-5.15%
Price vs 200-day SMA
4.97%
RSI
43.09
RSI Monthly
0
RSI Weekly
51.01
Sharpe ratio
1.2x
Sortino ratio
1.95
Total Return
7.12%
Tr YTD
8.3
Tr1m
-4.74%
Tr1w
0.52%
Tr3m
-3.1%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 16B
Operating Income Growth
4.47
Operating Income Growth Q
-12.37
Operating Income Growth3 Y
20.99
Operating Income Growth5 Y
10.06
Operating margin
32.56

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
1,816,121,384%
Net Borrowing
12,317,496,012
Shares Insiders
0.11%
Shares Institutions
44.44%
Shares Qo Q
-0.67%
Shares Yo Y
-3.8%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

60
MetricValue
Adjusted FCF
EUR 14.2B
Average Volume
914.55x
Bv Per Share
17.51
CAPEX
EUR -1.4B
Ch1m
-4.74
Ch1w
0.52
Ch1y
26.65
Ch3m
-5.97
Ch6m
12.84
Change
0.5%
Change From Open
1.03
Close
123.5
Days Gap
-0.52
Depreciation Amortization
3,814,981,038
Dollar Volume
26,685.8
Earnings Date
2026-04-28
EBIT
EUR 16B
EBITDA
EUR 19.9B
EPS
EUR 6.05
F Score
5
FCF
EUR 15.2B
FCF EV Yield
5.59x
Financing CF
-2,376,402,000
Fiscal Year End
December
Founded
1,996
Goodwill
22,741,492,878
Graham Number
49.5889
Graham Upside
-60.05
Income Tax
EUR 2B
Investing CF
-14,694,663,900
Is Primary Listing
0
Last Earnings Date
2026-04-28
Last Report Date
2026-03-31
Last Split Date
2001-05-07
Last Split Type
Forward
Lynch Fair Value
EUR 69.12
Lynch Upside
-44.31
Ma150
122.7
Ma150ch
1.2%
Ma20
126.2
Ma20ch
-1.68%
Net CF
-163,919,700
Next Earnings Date
2026-07-21
Open
122.9
P FCF Ratio
15.54
P OCF Ratio
14.21
Payment Date
2026-03-12
Position In Range
100
Ppne
10,377,358,956
Price Date
2026-05-08
Price EBITDA
EUR 11.89
Relative Volume
0.24x
Revenue
49,070,099,400x
SBC By Revenue
2.01x
Share Based Comp
986,120,100
Tax By Revenue
4.01x
Tax Rate
14.38%
Tr6m
16.27%
Volume
215
Z Score
3.27
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

FRA/NOT dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+3.3%
$4.10 annual per share
Payout ratio
+64.1%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+5.9%
4 consecutive years of growth
Total shareholder yield
+7.1%
Next ex-dividend date: 2026-03-10
Performance

FRA/NOT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+30.5%
S&P 500 1Y: n/a
3Y total return
n/a
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns FRA/NOT?

Insider, institutional, and short-interest positioning.

Institutional ownership
+44.4%
Share of float held by funds and institutions
Insider ownership
+0.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-3.8%
Negative means the company is buying back shares.
Technical

FRA/NOT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
43.1
Neutral momentum band
Price vs 200-day MA
+5.0%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
1.20
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/NOT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/NOT stock rating?

fra/NOT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/NOT analysis?

The full report lives at /stocks/fra/NOT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/NOT?

The latest report frames fra/NOT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/NOT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

fra/NOT stock profile: metrics, valuation and analysis | StockMarketAgent.AI